Concepedia

Holly Koelkebeck

HK

Statistics

Publications

4

Citations

107

H-Index

4

Active since

2016

Affiliations

AstraZeneca (United States)(Current)

University of California, San Francisco

Holly Koelkebeck is an author at AstraZeneca (United States) specializing in inflammation, medicine, and immunology.

Publications per year

2016–2021

4

Publications

4

Critical Role of Alpha-Toxin and Protective Effects of Its Neutralization by a Human Antibody in Acute Bacterial Skin and Skin Structure Infections

Vien T. M. Le, Christine Tkaczyk, Sally Chau et al. · Antimicrobial Agents and Chemotherapy · 2016 · 45 citations · Full text

, , +10

Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses

Bo Chen, Katherine A. Vousden, Brian Naiman et al. · Annals of the Rheumatic Diseases · 2018 · 36 citations · Full text

, , +17

High glypican-3 expression characterizes a distinct subset of ovarian clear cell carcinomas in Canadian patients: an opportunity for targeted therapy

Katharina Wiedemeyer, Martin Köbel, Holly Koelkebeck et al. · Human Pathology · 2020 · 14 citations

, , +15

Multimechanistic Monoclonal Antibody Combination Targeting Key Staphylococcus aureus Virulence Determinants in a Rabbit Model of Prosthetic Joint Infection

Yanjie Mao, Florent Valour, Nhu T. Q. Nguyen et al. · Antimicrobial Agents and Chemotherapy · 2021 · 12 citations · Full text

, , +17

1–4 of 4